Health24.com | Wuhan study shows how social distancing to curb the spread of coronavirus is saving lives

In a lesson for what can be achieved with social distancing, researchers report that school and workplace closures in Wuhan, China, reduced the number of coronavirus cases there.

And officials are extending those measures until April now instead of March, which could hold off a second wave of cases until later this year, the researchers noted.

Experts say there are vital lessons in the Wuhan experience for the United States and other countries around the world.

Gradually relax restrictions

“The unprecedented measures the city of Wuhan has put in place to reduce social contacts in school and the workplace have helped to control the outbreak,” said study leader Kiesha Prem, from the London School of Hygiene & Tropical Medicine, in England.

“However, the city now needs to be really careful to avoid prematurely lifting physical-distancing measures, because that could lead to an earlier secondary peak in cases,” Prem warned. Instead, “if they relax the restrictions gradually, this is likely to both delay and flatten the peak,” he said.

The closures significantly delayed the peak of the epidemic in Wuhan – the epicenter of the worldwide pandemic – and gave the health system the time and opportunity to grow and respond to the crisis, according to the study authors.

The researchers used mathematical modeling to simulate the impact of either extending or relaxing current school and workplace closures in Wuhan.

The results showed that by lifting these control measures in March, a second wave of cases may occur in late August. But maintaining these restrictions until April would likely delay a second peak until October.

The study was published in The Lancet Public Health.

Avoiding subsequent waves of infection

The researchers noted that due to uncertainties about how many people a person with the virus is likely to infect, and how long a person is infected, on average, it’s difficult to assess the actual impact of earlier lifting of school and workplace closures in Wuhan.

“Our results won’t look exactly the same in another country, because the population structure and the way people mix will be different,” said study co-author Yang Liu, also from the London School of Hygiene & Tropical Medicine.

“But we think one thing probably applies everywhere: physical-distancing measures are very useful, and we need to carefully adjust their lifting to avoid subsequent waves of infection when workers and school children return to their normal routine,” Liu said in a journal news release. “If those waves come too quickly, that could overwhelm health systems.”

The study is “crucial for policy makers everywhere,” Tim Colbourn, of University College London, wrote in an accompanying journal editorial.

“Given many countries with mounting epidemics now potentially face the first phase of lockdown, safe ways out of the situation must be identified,” he wrote.

“New Covid-19 country-specific models should incorporate testing, contact tracing and localised quarantine of suspected cases as the main alternative intervention strategy to distancing lockdown measures, either at the start of the epidemic, if it is very small, or after the relaxation of lockdown conditions, if lockdown had to be imposed, to prevent health-care system overload in an already mounting epidemic.”

Just this week, President Donald Trump said he wanted to lift stringent social-distancing measures in the United States by Easter, 12 April. But during a Tuesday media briefing, he said that he would listen to the advice of public health experts who are constantly analysing data on the outbreak.

READ | What does self-quarantine to prevent the spread of coronavirus look like?

READ | My story of social distancing: It’s okay to not be okay right now

WATCH | 4 Ways to prevent loneliness while social distancing

Image credit: Getty Images

Share Button

Clap for Carers: UK in ’emotional’ tribute to NHS and care workers

The Royal Family joined people around the UK to salute healthcare workers battling the virus outbreak.

Share Button

Coronavirus: UK deaths rise by more than 100 in a day

The death toll has risen from 475 to 578, the Department of Health and Social Care confirms.

Share Button

Worldwide scientific collaboration unveils genetic architecture of gray matter

The cerebral cortex is the relatively thin, folded, outer “gray matter” layer of the brain crucial for thinking, information processing, memory, and attention. Not much has been revealed about the genetic underpinnings that influence the size of the cortex’s surface area and its thickness, both of which have previously been linked to various psychiatric traits, including schizophrenia, bipolar disorder, depression, attention deficit hyperactivity disorder (ADHD), and autism.

Now, for the first time, more 360 scientists from 184 different institutions — including UNC-Chapel Hill — have contributed to a global effort to find more than 200 regions of the genome and more than 300 specific genetic variations that affect the structure of the cerebral cortex and likely play important roles in psychiatric and neurological conditions.

The study, published in Science, was led by co-senior authors Jason Stein, PhD, assistant professor in the Department of Genetics at the UNC School of Medicine; Sarah Medland, PhD, senior research fellow at the QIMR Berghofer Medical Research Institute in Australia; and Paul Thompson, PhD, associate director of the Mark and Mary Stevens Neuroimaging and Informatics Institute at the University of Southern California. Ten years ago, these scientists cofounded the ENIGMA Consortium, an international research network that has brought together hundreds of imaging genomics researchers to understand brain structure, function, and disease based on brain imaging and genetic data.

“This study was only possible due to a huge scientific collaboration of more than 60 sites involved in MRI scanning and genotyping participants,” Stein said. “This study is the crown jewel of the ENIGMA Consortium, so far.”

The researchers studied MRI scans and DNA from more than 50,000 people to identify 306 genetic variants that influence brain structure in order to shed light on how genetics contribute to differences in the cerebral cortex of individuals. Genetic variants or variations are simply the slight genetic differences that make us unique. Generally speaking, some variants contribute to differences such as hair color or blood type. Some are involved in diseases. Most of the millions of genetic variants, though, have no known significance. This is why pinpointing genetic variants associated with cortex size and structure is a big deal. Stein and colleagues consider their new genetic roadmap of the brain a sort of “Rosetta stone” that will help translate how some genes impact physical brain structure and neurological consequences for individuals.

Among the findings of the research published in Science:

  • Some genetic variants are associated with cortical folding, measured as surface area, while other genetic variants are associated with the thickness of the cortex.
  • Genes that determine surface area are related to very early development in the fetal cortex, while thickness appears to be driven by genes active in the adult cortex.
  • People at genetic risk for depression or insomnia are genetically inclined toward having lower surface area, while people with a genetic risk for Parkinson’s disease tend to have higher surface area.
  • The vast scale of the project allowed the discovery of specific genes that drive brain development and aging in people worldwide.

“Most of our previous understanding of genes affecting the brain are from model systems, like mice,” Stein said. “With mice, we can find genes, knock out genes, or over express genes to see how they influence the structure or function of the brain. But there are a couple of problems with this.”

One problem is, quite simply, a mouse is not a human. There are many human-specific features that scientists can only study in the human brain.

“The genetic basis for a mouse is very different than the genetic basis for humans,” Stein said, “especially in in the noncoding regions of the genome.”

Genes contain DNA, the basic human code that, when translated into action, creates proteins that “do” things, such as help your finger muscles type or your heart beat or your liver process toxins. But only about 3 percent of the human genome codes for proteins. The vast majority of the human genome is called the noncoding genome. Much of this region is not shared between mice and humans. This noncoding genome consists of tiny molecular switches that can modulate the expression of other genes. These switches don’t directly alter the function of a protein, but they can affect the amounts of a protein that is expressed. Turns out, most genetic variants associated with psychiatric disorders are found in the noncoding region of the genome.

These findings can now be a resource for scientists to help answer important questions about the genetic influences on the brain and how they relate to numerous conditions.

Aysenil Berger, PhD, director of Psychiatry Neuroimaging Research and director of the Frank Porter Graham Child Development Institute at UNC-Chapel Hill, is a co-author on the study.

The study was funded by national and international public and private funding agencies, including the National Institutes of Health, the Australian National Health and Medical Research Council, the Michael J. Fox Foundation, and the Kavli Foundation.

Share Button

How to identify factors affecting COVID-19 transmission

Much remains unknown about how SARS-CoV-2, the virus that causes COVID-19, spreads through the environment. A major reason for this is that the behaviors and traits of viruses are highly variable — some spread more easily through water, others through air; some are wrapped in layers of fatty molecules that help them avoid their host’s immune system, while others are “naked.”

This makes it urgent for environmental engineers and scientists to collaborate on pinpointing viral and environmental characteristics that affect transmission via surfaces, the air and fecal matter, according to Alexandria Boehm, a Stanford professor of civil and environmental engineering, and Krista Wigginton, the Shimizu Visiting Professor in Stanford’s department of civil and environmental engineering and an associate professor at the University of Michigan.

Boehm and Wigginton co-authored a recently published viewpoint in Environmental Science & Technology calling for a broader, long-term and more quantitative approach to understanding viruses, such as SARS-CoV-2, that are spread through the environment. They are also principal investigators on a recently announced National Science Foundation-funded project to study the transfer of coronaviruses between skin and other materials, the effect of UV and sunlight on the coronaviruses, and the connection between disease outbreaks and virus concentrations in wastewater.

Scientists and medical experts don’t have a good understanding of what virus characteristics and environmental factors control virus persistence in the environment — for example, in aerosols and droplets, on surfaces including skin and in water including seawater, according to Boehm and Wigginton. “When a new virus emerges and poses a risk to human health, we don’t have a good way of predicting how it will behave in the environment,” Boehm said.

Part of the problem is historically there has been limited funding for this sort of work. The National Institutes of Health historically hasn’t funded work on pathogens in the environment, and funding at the National Science Foundation for this work is limited. Also, coronaviruses and most of the emerging viruses that have caught the world’s attention over the last decade are enveloped viruses that are wrapped in an outer layer of fatty lipid molecules that they’ve stolen from their hosts. Proteins on the surface of the envelopes can help these viruses evade the immune systems of the organisms they are infecting. “There has been much more work on the fate of non-enveloped or naked viruses because most intestinal pathogens in excrement are nonenveloped viruses — like norovirus and rotavirus,” said Wigginton.

In their paper, Boem and Wigginton address potential threats that viruses such as SARS-CoV-2 pose to water sources. We usually only worry about viruses in water if they are excreted by humans in their feces and urine. Most enveloped viruses aren’t excreted in feces or urine, so they aren’t usually on our minds when it comes to our water sources. There is increasing evidence that the SARS-CoV-2 viruses, or at least their genomes, are excreted in feces. If infective viruses are excreted, then fecal exposure could be a route of transmission, according to Boehm, who added, “It’s unlikely this could be a major transmission route, but a person could potentially be exposed by interacting with water contaminated with untreated fecal matter.”

Drinking water treatment systems have numerous treatment barriers to remove the most prevalent viruses and the most difficult-to-remove viruses, according to the engineers. Research on viruses similar to the SARS-CoV-2 virus suggests they are susceptible to these treatments. “In terms of virus concentration and persistence, this isn’t a worst-case scenario,” Wigginton said.

Broadly, Wigginton and Boehm write, we tend to study viruses very intensely when there is an outbreak, but the results from one virus aren’t easy to extrapolate to other viruses that emerge years later. “If we took a broader approach to studying many kinds of viruses, we could better understand the characteristics driving their environmental fate,” Wigginton said.

The two researchers call for experts across various fields — including medicine and engineering and — to work together to move methods forward faster, make discoveries and formulate strategies that wouldn’t be possible independently.

Story Source:

Materials provided by Stanford University. Original written by Rob Jordan. Note: Content may be edited for style and length.

Share Button

In politics and pandemics, trolls use fear, anger to drive clicks

Facebook users flipping through their feeds in the fall of 2016 faced a minefield of targeted advertisements pitting blacks against police, southern whites against immigrants, gun owners against Obama supporters and the LGBTQ community against the conservative right.

Placed by distant Russian trolls, they didn’t aim to prop up one candidate or cause, but to turn Americans against one another.

The ads were cheaply made and full of threatening, vulgar language.

And, according to a sweeping new analysis of more than 2,500 of the ads, they were remarkably effective, eliciting clickthrough rates as much as nine times higher than what is typical in digital advertising.

“We found that fear and anger appeals work really well in getting people to engage,” said lead author Chris Vargo, an assistant professor of Advertising, Public Relations and Media Design at University of Colorado Boulder.

The study, published this week in Journalism and Mass Communication Quarterly, is the first to take a comprehensive look at ads placed by the infamous Russian propaganda machine known as the Internet Research Agency (IRA) and ask: How effective were they? And what makes people click on them?

While focused on ads running in 2016, the study’s findings resonate in the age of COVID-19 and the run-up to the 2020 election, the authors say.

“As consumers continue to see ads that contain false claims and are intentionally designed to use their emotions to manipulate them, it’s important for them to have cool heads and understand the motives behind them,” said Vargo.

For the study, Vargo and assistant professor of advertising Toby Hopp scoured 2,517 Facebook and Instagram ads downloaded from the U.S. House of Representatives Permanent Select Committee On Intelligence website. The committee made the ads publicly available in 2018 after concluding that the IRA had been creating fake U.S. personas, setting up fake social media pages, and using targeted paid advertising to “sow discord” among U.S. residents.

Using computational tools and manual coding, Vargo and Hopp analyzed every ad, looking for the inflammatory, obscene or threatening words and language hostile to a particular group’s ethnic, religious or sexual identity. They also looked at which groups each ad targeted, how many clicks the ad got, and how much the IRA paid.

Collectively, the IRA spent about $75,000 to generate about 40.5 million impressions with about 3.7 million users clicking on them — a clickthrough rate of 9.2%.

That compares to between .9% and 1.8% for a typical digital ad.

While ads using blatantly racist language didn’t do well, those using cuss words and inflammatory words (like “sissy,” “idiot,” “psychopath” and “terrorist”) or posing a potential threat did. Ads that evoked fear and anger did the best.

One IRA advertisement targeting users with an interest in the Black Lives Matter movement stated: “They killed an unarmed guy again! We MUST make the cops stop thinking that they are above the law!” Another shouted: “White supremacists are planning to raise the racist flag again!” Meanwhile, ads targeting people who sympathized with white conservative groups read “Take care of our vets; not illegals” or joked “If you voted for Obama: We don’t want your business because you are too stupid to own a firearm.”

Only 110 out of 2,000 mentioned Donald Trump.

“This wasn’t about electing one candidate or another,” said Vargo. “It was essentially a make-Americans-hate-each-other campaign.”

The ads were often unsophisticated, with spelling or grammatical errors and poorly photoshopped images. Yet at only a few cents to distribute, the IRA got an impressive rate of return.

“I was shocked at how effective these appeals were,” said Vargo.

The authors warn that they have no doubt such troll farms are still at it.

According to some news reports, Russian trolls are already engaged in disinformation campaigns around COVID-19.

“I think with any major story, you are going to see this kind of disinformation circulated,” said Hopp. “There are bad actors out there who have goals that are counter to the aspirational goals of American democracy, and there are plenty of opportunities for them to take advantage of the current structure of social media.”

Ultimately, the authors believe better monitoring, via both machine algorithms and human reviewers, could help stem the tide of disinformation.

“We as a society need to start seriously talking about what role the platforms and government should play in times like the 2020 election or during COVID-19 when we have a compelling need for high-quality, accurate information to be distributed,” said Hopp.

Share Button

Health24.com | Coronavirus news on social media stressing you out? Here’s how to handle the anxiety

A coronavirus pandemic. Politics. An upending of life at a level that few have ever experienced. And all of it amplified by social media.

The ever-shifting news has some people constantly checking their phones for updates – and others saying they’re ready to walk away from their feeds entirely.

“It’s really the perfect recipe for anxiety and panic,” said licensed clinical psychologist Debra Kissen of Chicago. And stress, it should be noted, may be a factor in heart disease.

But Kissen, CEO of Light on Anxiety CBT Treatment Center, and others, say anxiety can be managed – and social media, used properly, doesn’t have to send you on a mental-health spiral. It also can help you find balance.

What can I do to protect myself?

Kissen acknowledged the coronavirus pandemic is unprecedented because of the way uncertainty has crept into “every little nook and cranny” of life. People worry: Is your neighbour’s cough going to be the one? Is that touch going to be what does you in? Will I get infected in the supermarket?”

Your brain’s response to such uncertainty is the very definition of anxiety, she said.

“Anxiety is all about a future ‘what if?'” Kissen said. “Is something bad going to happen, and what can I do to protect myself?”

In the face of a visible threat, your brain can choose a course of action – say, fight or flight. But amid uncertainty, your brain looks for what it can control, even when nothing helpful can be done. That’s when problems can start.

Some people keep looking for actions to take, following unhealthy impulses that say, “Let me hoard more. Let me read more,” she said, “versus accepting that there are just limits to my control at this point.”

Keith Hampton, a professor in the department of media and information at Michigan State University in East Lansing, said social media amplifies stress by giving us a personal connection to people experiencing bad news directly.

But Hampton, who led a study for the Pew Research Center about this “cost of caring”, said our relationship with social media doesn’t have to be all negative.

Positive information can be contagious

“We know, for example, that people who use more social media tend to perceive there’s more social support available to them” from friends and family, online and offline, he said.

And when people experience positive things, he said, they also get a bit of a psychological uplift.
So, part of the solution to managing social media in a time of high anxiety is to make sure you’re sharing not just what alarms you, but whatever good news you experience as well.

Knowing people are safe and improving, “that type of positive information can be contagious”, he said.

Which is part of why he doesn’t recommend turning off social media entirely.

We may need social distancing, the practice of creating physical space between you and another person to prevent spread of the virus. But, he said that this is not a time for social isolation.

“This is a time for seeking and giving social support to those who need it. And social media can be a very powerful tool for checking on friends and family, for providing emotional support to those who are in need to organizing to provide resources to neighbours, to the elderly, to children, to those people who are no longer getting or can’t access the resources that they need.”

Key to reducing anxiety

But, he and Kissen said, be mindful about how you use it.

Keeping up with high-quality information is vital. “We can’t put our heads in the sand and pretend this is not happening, because that’s not healthy or good,” Kissen said. So, pick a news source, decide, “OK, I’m going to allow myself like 30 minutes a day, or 10 high-quality articles, and check in with them.”

Keeping your worried brain off of autopilot through mindfulness is the key to reducing anxiety in all aspects of life, she said. “It’s not some hokey spiritual voodoo. It’s about enhancing one’s ability to return to the present moment.”

Apps for CBT – cognitive behavioural therapy – can be helpful, she said. So can time-honoured tricks such as getting exercise, taking a walk and being active.

No more to be done

“Think of a computer that has 20 windows open and is frozen because there’s too much going on,” she said. That forces a reboot. “What do we do to reboot ourselves? Is it a jumping jack? Is it just standing up and stretching? Is it getting fresh air? What kind of input can we give our body to kind of move on and get unstuck?”

Overall, she said, the goal is to break that endless loop of anxious anticipation.

Your brain may say, “shouldn’t I be doing more? Shouldn’t I be doing more?” Kissen said. “But sometimes there’s just not more to be done.”

READ | Coronavirus 101 – here’s what you need to know

READ | Coronavirus: Basic protective measures

READ | Coronavirus: When and how to use masks

Image credit: iStock

Share Button

Coronavirus: NHS uses tech giants to plan crisis response

Amazon and Microsoft are among those helping with a dashboard to model where ventilators should go.

Share Button

Health24.com | One key way to curb coronavirus spread in US: more paid sick leave

As the coronavirus makes its way across America, imagine you are a waitress with no paid sick leave and children at home. Rather than falling ill from a case of COVID-19, your biggest worry is losing pay, or possibly your job. So, if you don’t feel well, you still go to work.

Experts say that personal dilemma is also a public dilemma, because it drastically increases the risk of spreading the virus in the community.

One actual example of the dilemma: Euqueva Varner, 33, a security guard in Detroit, told CBS News that she felt under the weather on Monday, but she still showed up for work because she doesn’t get paid sick time. “I had the chills, and my body was cold but I was hot. I had a headache, and I wasn’t my normal self,” she told the news outlet.

Varner is not alone in not having paid sick time. Nearly one-third of American workers don’t have paid sick leave, including 69% of part-time employees, according to the US Bureau of Labor Statistics. Only seven states require employers to provide paid sick leave.

Paid sick leave

What’s the solution?

As nations struggle to stem the spread of the new coronavirus, employees may need to be given paid time off from work to either self-quarantine or to recover from the illness, said LeaAnne DeRigne, an associate professor in the School of Social Work at Florida Atlantic University.

On Tuesday, the New York Times went even further: “Congress can help by mandating that workers receive paid time off if they fall ill, or if they need to care for an ailing family member. Such a policy is necessary both to impede the spread of the virus and its economic harm,” the editorial said.

“Most developed nations require employers to provide some form of paid sick leave, and the United States should do so, too. Some states already mandate sick leave, and a recent study found that the adoption of such laws reduced cases of influenza by 11% in their first year,” the editorial noted.

Congress could mandate sick leave specifically for this coronavirus, which would produce a huge effect, the editorial added. A 2013 study of Pennsylvania workers estimated that allowing them to take up to two paid “flu days” would have reduced workplace transmission of the flu by roughly 39%.

Aside from helping stem the spread of coronavirus, if a coronavirus vaccine becomes available, workers would be more likely to get it if they have paid time off from work, DeRigne said.

Research shows a link between paid sick leave and workers getting vaccinations, according to DeRigne and Patricia Stoddard-Dare, a professor at the School of Social Work at Cleveland State University. The two have conducted numerous studies on the lack of paid sick leave in the United States.

No choice but to go to work

They said that during the 2009 H1NI outbreak, sick workers who didn’t stay home exposed an additional 7 million people to the virus. It’s estimated that lack of paid sick leave resulted in an additional 1 500 deaths during the outbreak.

“Now is the time to consider the importance of having access to guaranteed paid sick days in public health epidemics,” DeRigne said in a Florida Atlantic University news release.

“Those who lack paid sick leave are highly represented among food service workers, day care workers, and home health aides who work in positions that can greatly influence the health of others, especially the elderly, vulnerably ill and children,” she explained.

“It is dangerous when any employees are sick with highly contagious viruses but have no other choice but to report to work or else lose wages. Paid sick leave also allows working parents the opportunity to care for their sick children rather than sending them to school when they show signs of contagious illness,” DeRigne said.

“People use paid sick leave days to care for themselves or their family members who have acute health problems and to get adequate rest to avert escalation of the condition,” Stoddard-Dare said in the release. “In order to comply with public health recommendations, Americans need access to guaranteed sick leave.”

Image credit: iStock

Share Button

Patients at risk of drug-induced sudden cardiac death in COVID-19

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it’s still likely 12 to 18 months away.

In the meantime, the pandemic, with over 400,000 confirmed cases worldwide already, is driving researchers to find safe and effective therapies for patients with COVID-19, and an antimalarial drug is potentially on the front lines of that effort. While new and repurposed drugs are being tested in clinical trials, some of these promising drugs are simultaneously being used off-label for compassionate use to treat patients.

Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the health of the heart’s electrical recharging system. Patients with a dangerously prolonged QTc are at increased risk for potentially life-threatening ventricular rhythm abnormalities that can culminate in sudden cardiac death.

“Correctly identifying which patients are most susceptible to this unwanted, tragic side effect and knowing how to safely use these medications is important in neutralizing this threat,” says Michael J. Ackerman, M.D., Ph.D., a Mayo Clinic genetic cardiologist. Dr. Ackerman is director of the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program.

A study published in Mayo Clinic Proceedings details more information about potential dangers and the application of QTc monitoring to guide treatment when using drugs that can cause heart rhythm changes. Dr. Ackerman is the senior author of the study.

Hydroxychloroquine is a long-standing preventive and treatment drug for malaria. It also is used to manage and minimize symptoms of inflammatory immune diseases, such as lupus and rheumatoid arthritis. In laboratory tests, hydroxychloroquine can prevent the SARS-CoV and SARS-CoV-2 viruses from attaching to and entering cells. If these antiviral abilities work the same way in animals and humans, the drug could be used to treat patients and limit the number of COVID-19 deaths.

On a cellular level, potential QT-prolonging medications, like hydroxychloroquine, block one of the critical potassium channels that control the heart’s electrical recharging system. This interference increases the possibility that the heart’s rhythm could degenerate into dangerous erratic heart beats, resulting ultimately in sudden cardiac death.

Accordingly, Mayo Clinic cardiologists and physician-scientists have provided urgent guidance on how to use a 12-lead ECG, telemetry or smartphone-enabled mobile ECG to determine the patient’s QTc as a vital sign to identify those patients at increased risk and how to ultimately minimize the chance of drug-induced sudden cardiac death.

“Right now, it is the Wild West out there, ranging from doing no QTc surveillance whatsoever and just accepting this potential tragic side effect as part of ‘friendly fire,’ to having ECG technicians going into the room of a patient with COVID-19 daily, exposing them to coronavirus and consuming personal protective equipment,” says Dr. Ackerman. “Here Mayo Clinic has stepped forward to provide timely and critical guidance.”

Guidelines for QTc monitoring during treatment

The antimalarial drugs chloroquine and hydroxychloroquine, as well as the HIV drugs lopinavir and ritonavir, all carry a known or possible risk of drug-induced ventricular arrhythmias and sudden cardiac death. Prior to starting treatment with these medications, it is important to get a baseline ECG to be able to measure changes. This starting point measurement could be from a standard 12-lead ECG, telemetry or a smartphone-enabled mobile ECG device. On Monday, March 20, the Food and Drug Administration (FDA) granted emergency approval of AliveCor’s Kardia 6L mobile ECG device as the only FDA-approved mobile device for QTc monitoring with COVID-19.

The mobile device’s ability to remotely provide the patient’s heart rhythm and QTc value does not require an extra ECG technician to take the measurement in person, thus saving increased exposure to COVID-19 and the need for more personal protective equipment.

Using the algorithm developed by Dr. Ackerman and colleagues, the potential risk of drug-induced arrhythmias can be rated and used to modify treatment accordingly. For example, patients with a baseline QTc value greater than or equal to 500 milliseconds and those that experience an acute QTc reaction with a QTc greater than or equal to 60 milliseconds from baseline after starting treatment with one or more QTc-prolonging drugs are at greatest risk for drug-induced arrhythmias. Simple QTc countermeasures can be implemented for patients with a cautionary “red light” QTc status if the decision is made to proceed with the intended COVID-19 therapies.

Information guides decisions

There are a number of considerations around the use of off-label drugs to treat COVID-19. The drugs may or may not be available in large enough supply to treat a worldwide pandemic, even at the current compassionate use stage of testing. It will take careful consideration of COVID-19 patients’ circumstances for treating clinicians and patients to decide on the use of drugs or drug combinations that may treat their infection, but which potentially could cause harmful drug-induced side effects.

Dr. Ackerman says that patients under 40 with mild symptoms and a QTc greater than or equal to 500 milliseconds may choose to avoid treatment altogether, as the arrhythmia risk may far outweigh the risk of developing COVID-19-related acute respiratory distress syndrome. However, in COVID-19 patients with a QTc greater than or equal to 500 milliseconds who have progressively worsening respiratory symptoms or are at greater risk of respiratory complications due to advanced age, immunosuppression or having another high-risk condition, the potential benefit of QTc-prolonging medicines may exceed the arrhythmia risk.

“Importantly, the vast majority of patients ? about 90% ? are going to be QTc cleared with a ‘green light go’ and can proceed, being at extremely low risk for this side effect,” says Dr. Ackerman.

Ultimately, the weighing of risks to benefits depends on whether hydroxychloroquine, with or without azithromycin, is truly an effective treatment against COVID-19.

“If it is, we hope that this simple QTc surveillance strategy, enabled by innovation and the FDA’s emergency approval, will help prevent or at least significantly minimize drug-induced ventricular arrhythmias and sudden cardiac death, particularly if the treatment is widely adopted and used to treat COVID-19,” says Dr. Ackerman.

Other contributors to the study are John Giudicessi, M.D., Ph.D., first author; Peter Noseworthy, M.D.; and Paul Friedman, M.D. — all Mayo Clinic cardiologists. Drs. Ackerman, Friedman and Noseworthy have a financial interest in AliveCor.

Share Button